PLTR vs ZYME · P/E 584, rev $4.48B vs rev $76.3M
Palantir Technologies Inc. Class A Common Stock (PLTR) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported PLTR revenue for 2025-12-31 was $4.48B. Net income was $1.63B. Revenue was up 56.2% from 2024-12-31 to 2025-12-31. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
PLTR currently screens at market cap $317.08B and trailing P/E 584.2. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the PLTR and ZYME stock pages for the full models.
Not investment advice.